作者：
Kogieleum,Naidoo [1]
;
Anushka,Naidoo [2]
;
Alash'le G,Abimiku [3]
;
Everdina W,Tiemersma [4]
;
Agnes,Gebhard [4]
;
Sabine M,Hermans [5]
;
Derek J,Sloan [6]
;
Morten,Ruhwald [7]
;
Sophia B,Georghiou [7]
;
Evaezi,Okpokoro [8]
;
Aderonke,Agbaje [8]
;
Kalkidan,Yae [9]
;
Getachew,Tollera [10]
;
Shewki,Moga [10]
;
Hannelise,Feyt [11]
;
Takondwa,Kachoka [11]
;
Marothi P,Letsoalo [12]
;
Andrea M,Cabibbe [13]
;
Rubeshan,Perumal [2]
;
Letitia,Shunmugam [2]
;
Daniela M,Cirillo [13]
;
Salah,Foraida [14]
;
Wilber,Sabiiti [6]
;
Nyanda Elias,Ntinginya [15]
;
Bariki,Mtafya [15]
;
Ahmed,Bedru [9]
;
Stephen H,Gillespie [6]
;
TRiAD Study Consortium
作者单位：
Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa Kogie.Naidoo@caprisa.org.;SAMRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
[1]
Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa.;SAMRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
[2]
International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.;University of Maryland School of Medicine, Baltimore, Maryland, USA.
[3]
Koninklijke Nederlandse Centrale Vereniging tot Bestrijding der Tuberculose, The Hague, The Netherlands.
[4]
Amsterdam UMC location University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
[5]
University of St Andrews, St Andrews, UK.
[6]
Foundation for Innovative New Diagnostics, Geneva, Switzerland.
[7]
International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.
[8]
Koninklijke Nederlandse Centrale Vereniging tot Bestrijding der Tuberculose, Addis Ababa, Ethiopia.
[9]
Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
[10]
Clinical HIV Research Unit (CHRU), Jose Pearson TB Hospital, Wits Health Consortium Pty Ltd, Port Elizabeth, South Africa.
[11]
Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa.
[12]
Emerging bacterial pathogens, Ospedale San Raffaele, Milano, Italy.
[13]
Global Alliance for TB Drug Development, New York, New York, USA.
[14]
National Institute for Medical Research, Dar es Salaam, United Republic of Tanzania.
[15]
DOI
10.1136/bmjopen-2024-084722
PMID
39609025
发布时间
2024-12-12
换一批
换一批
